Durapatite clinical trials
How each study uses Durapatite is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Durapatite studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2019 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
University of California, Irvine (1) · Kalpna Kay Durairaj, MD, FACS (1) · DeNova Research (1) · Heba Tahseen Almasri (1) · Indonesia University (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Durapatite.
- Nov 2026Effect of Hydroxyapatite Toothpaste and Mouthwash in Preventing White Spot Lesions During Orthodontic TreatmentNot applicable · Heba Tahseen Almasri
Studies
Open first, then newest update. How each study uses Durapatite is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Effect of Hydroxyapatite Toothpaste and Mouthwash in Preventing White Spot Lesions During Orthodontic TreatmentRecruitingNot applicableHeba Tahseen AlmasriNCT07325643Written as Hydroxyapatite Mouthwash
- Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume RestorationCompletedPhase 1University of California, IrvineNCT04176068Written as calcium hydroxylapatite (Radiesse) and IFUS (Ulthera)
- Effects of Calcium Hydroxylapatite on Cellulite Dimples in the ButtocksCompletedPhase 1Kalpna Kay Durairaj, MD, FACSNCT05885035Written as Calcium Hydroxyapatite
- Injectable Filler for Cheek FlatteningCompletedPhase 4DeNova ResearchNCT01225354Written as Calcium hydroxylapatite
- Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion FractureStatus unknownPhase 1Indonesia UniversityNCT01626625Written as stem cells + hydroxy apatite
As the comparator · 1 — what is tested is compared with Durapatite
Codes
What other systems call Durapatite · ClinicalTrials.gg INT008618
- MeSH (NLM) D017886DurapatiteOne source NLM
- UNII (FDA) 91D9GV0Z28TRIBASIC CALCIUM PHOSPHATEConfirmed FDA, NLM
- RxNorm 49334One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017886 | Durapatite | One source NLM |
| UNII (FDA) | 91D9GV0Z28 | TRIBASIC CALCIUM PHOSPHATE | Confirmed FDA, NLM |
| RxNorm | 49334 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.